Clinical Trials
24 trialsClinical Genetics Branch Eligibility Screening Survey
National Institutes of Health Clinical Center (CC)
Clinical and Genetic Studies of Li-Fraumeni Syndrome
National Institutes of Health Clinical Center (CC)
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
National Institutes of Health Clinical Center (CC)
Li-Fraumeni Syndrome Imaging Study
The Hospital for Sick Children
SJFAMILY
St. Jude Children's Research Hospital
Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
M.D. Anderson Cancer Center
LiFT_UP
Dana-Farber Cancer Institute
Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes
Dana-Farber Cancer Institute
CHARM2
University Health Network, Toronto
Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni Syndrome
National Institutes of Health Clinical Center (CC)
NSM
Sir Mortimer B. Davis - Jewish General Hospital
ReLF
Istituto Ortopedico Rizzoli
Li-Fraumeni Syndrome/TP53 Biobank
Abramson Cancer Center at Penn Medicine
PILLCAM
Royal Marsden NHS Foundation Trust
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Universidad Nacional Autonoma de Mexico
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
ICED
Royal Marsden NHS Foundation Trust
BREAST-TP53
Instituto do Cancer do Estado de São Paulo
SIGNIFY
Institute of Cancer Research, United Kingdom
Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome
National Institutes of Health Clinical Center (CC)
LIFSCREEN
Gustave Roussy, Cancer Campus, Grand Paris
A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome
National Institutes of Health Clinical Center (CC)
Biomarker Monitoring in TP53 Mutation Carriers
Scripps Health